|
TSPAN17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.41129999908784E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.02690000003403E-06 |
| Normal-vs-Stage2 |
1.203730E-03 |
| Normal-vs-Stage3 |
3.040800E-04 |
| Normal-vs-Stage4 |
5.169600E-02 |
| Stage1-vs-Stage2 |
3.162400E-01 |
| Stage1-vs-Stage3 |
2.735600E-01 |
| Stage1-vs-Stage4 |
7.317000E-01 |
| Stage2-vs-Stage3 |
9.813200E-01 |
| Stage2-vs-Stage4 |
7.688600E-01 |
| Stage3-vs-Stage4 |
7.763000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.03519999928548E-08 |
| Normal-vs-AfricanAmerican |
3.127300000072E-07 |
| Normal-vs-Asian |
1.227770E-01 |
| Caucasian-vs-AfricanAmerican |
5.655400E-01 |
| Caucasian-vs-Asian |
3.505400E-01 |
| AfricanAmerican-vs-Asian |
6.450400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.93930000005993E-07 |
| Normal-vs-Female |
6.72790045896932E-10 |
| Male-vs-Female |
4.435600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.816900E-04 |
| Normal-vs-Extreme_Weight |
2.3235999999982E-05 |
| Normal-vs-Obese |
3.1041000000398E-06 |
| Normal-vs-Extreme_Obese |
5.221700E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.940400E-01 |
| Normal_Weight-vs-Obese |
5.055000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.871400E-01 |
| Extreme_Weight-vs-Obese |
3.319200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.959600E-01 |
| Obese-vs-Extreme_Obese |
9.378600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.28109999997239E-06 |
| Normal-vs-Age(41-60Yrs) |
4.22979995473582E-09 |
| Normal-vs-Age(61-80Yrs) |
1.04020000002425E-06 |
| Normal-vs-Age(81-100Yrs) |
6.909700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.907600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.924000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.802500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.637700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.682500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.427000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.46560000089136E-09 |
| Normal-VS-Type2 PRCC |
5.88369999999783E-05 |
| Normal-VS-KIRP CIMP |
2.005800E-02 |
| Normal-VS-Unclassified PRCC |
2.02090000001043E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.140620E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.217200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.693000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.708400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.734100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.835200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.247730E-04 |
| Normal-vs-N1 |
5.845300E-04 |
| Normal-vs-N2 |
1.431450E-01 |
| N0-vs-N1 |
4.059800E-01 |
| N0-vs-N2 |
1.038020E-01 |
| N1-vs-N2 |
2.819400E-01 |
|
|
